Dian Swastatika Sentosa Tbk vs Prodia Diagnostic Line Tbk — how do they compare? Dian Swastatika Sentosa Tbk trades at Rp990 (market cap 192.64T, 655.02M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Dian Swastatika Sentosa Tbk is far larger — about 409.4× Prodia Diagnostic Line Tbk's market cap, and Dian Swastatika Sentosa Tbk is more actively traded (655.02M versus 28.43M). Which is the better fit depends on your goals.
| DSSA | PRDL | |
|---|---|---|
Market Cap | 192.64T | 470.58B |
Volume | 655.02M | 28.43M |
Lot | 6.55M | 284.34K |
Turnover | 649.58B | 7.8B |
Average Price | 991.7 | 274.19 |
Value | 649.58B | 7.8B |
Indicative Equilibrium Price | 990 | 270 |
Indicative Equilibrium Volume | 73.9K | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Dian Swastatika Sentosa Tbk (the company) was established on August 2, 1996 based on Notarial Deed No. 6 and was amended by Notarial Deed No. 35 dated October 8, 1996, both of Linda Herawati, S.H., a public notary in Jakarta. The Company operates under the Sinarmas group of business.
Read more on DSSA →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →